The neuropsychology of normal aging and preclinical Alzheimer's disease
- 28 March 2013
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 10 (1) , 84-92
Abstract
Objective: A National Institute on Aging–sponsored work group on preclinical Alzheimer's disease (AD) articulated the need to characterize cognitive differences between normal aging and preclinical AD.Methods: Seventy‐one apolipoprotein E (APOE) ε4 homozygotes, 194 ε3/ε4 heterozygotes, and 356 ε4 noncarriers age 21 to 87 years who were cognitively healthy underwent neuropsychological testing every 2 years. Longitudinal trajectories of test scores were compared between APOE subgroups.Results: There was a significant effect of age on all cognitive domains in both APOE ε4 carriers and noncarriers. A significant effect of APOE ε4 gene dose was confined to the memory domain and the Dementia Rating Scale. Cross‐sectional comparisons did not discriminate the groups.Conclusions: Although cognitive aging patterns are similar in APOE ε4 carriers and noncarriers, preclinical AD is characterized by a significant ε4 gene dose effect that impacts memory and is detectable longitudinally. Preclinical neuropsychological testing strategies should emphasize memory‐sensitive measures and longitudinal design.Keywords
Funding Information
- National Institute on Aging (R01AG031581, P30AG19610)
- Arizona Alzheimer's Consortium
This publication has 48 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Cognitive Decline in Prodromal Alzheimer Disease and Mild Cognitive ImpairmentArchives of Neurology, 2011
- Amyloid load in nondemented brains correlates with APOE e4Neuroscience Letters, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Longitudinal Study of the Transition From Healthy Aging to Alzheimer DiseaseArchives of Neurology, 2009
- Longitudinal Modeling of Age-Related Memory Decline and theAPOEε4 EffectNew England Journal of Medicine, 2009
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjectsBrain, 2008
- Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's diseaseJournal of the International Neuropsychological Society, 2008